Anti-LDL Receptor antibody [EP1553Y]
- RabMAb
- KO Validated
- Recombinant
- What is this?
4
(16 Reviews)
|
(185 Publications)
Anti-LDL Receptor antibody [EP1553Y] (ab52818) is a rabbit monoclonal antibody detecting LDL Receptor in Western Blot, IHC-P. Suitable for Human, Mouse.
- KO validated for confirmed specificity
- Biophysical QC for unrivalled batch-batch consistency
- Over 140 publications
- Trusted since 2007
View Alternative Names
Low-density lipoprotein receptor, LDL receptor, LDLR
- WB
Lab
Western blot - Anti-LDL Receptor antibody [EP1553Y] (AB52818)
Anti-LDLR antibody [EP1553Y] (ab52818) staining at 1/1000 dilution, shown in green; Mouse anti-CANX [CANX/1543] (ab238078) loading control staining at 1/20000 dilution, shown in red. In Western blot, ab52818 was shown to bind specifically to LDLR. A band was observed at 130/160 kDa in wild-type HeLa cell lysates with no signal observed at this size in LDLR knockout cell line ab273838 (knockout cell lysate ab273792). To generate this image, wild-type and LDLR knockout HeLa cell lysates were analysed. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 5 % milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit IgG H&L 800CW and Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution.
All lanes:
Western blot - Anti-LDL Receptor antibody [EP1553Y] (ab52818) at 1/1000 dilution
Lane 1:
Wild-type HeLa cell lysate at 20 µg
Lane 2:
LDLR knockout HeLa cell lysate at 20 µg
Lane 3:
HepG2 cell lysate at 20 µg
Lane 3:
A431 cell lysate at 20 µg
Secondary
All lanes:
Goat anti-Rabbit IgG H&L 800CW and Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution
Predicted band size: 95 kDa
Observed band size: 130 kDa,160 kDa
false
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-LDL Receptor antibody [EP1553Y] (AB52818)
Immunohistochemical analysis of paraffin-embedded human liver sections labeling LDL Receptor with purified ab52818 at dilution of 1 : 500. The secondary antibody used was ab97051; a goat anti-rabbit IgG H&L (HRP) at dilution of 1/500. The sample was counterstained with hematoxylin. Antigen retrieval was performed using EDTA Buffer; pH 9.0. PBS was used instead of the primary antibody as the negative control and is shown in the inset.
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-LDL Receptor antibody [EP1553Y] (AB52818)
Immunohistochemical analysis of paraffin-embedded human hepatocellular carcinoma tissue labeling LDL Receptor with ab52818 at 1/100 dilution followed by goat anti-rabbit IgG H&L (HRP) (ab97051 1/500). The sample was counterstained with hematoxylin.
- IHC-P
Lab
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-LDL Receptor antibody [EP1553Y] (AB52818)
Immunohistochemical analysis of formalin fixed paraffin embedded human liver labelling LDL Receptor with ab52818 at a concentration of 0.5μg/ml. The immunostaining was performed on a Ventana DISCOVERY ULTRA (Roche Tissue Diagnostics) instrument with a OptiView DAB IHC Detection Kit. Heat mediated antigen retrieval was performed with DISCOVERY cell conditioning solution (CC1) 100°C, pH8.5 for 32mins.
ab52818 anti-LDL Receptor antibody [EP1553Y] was incubated for 16mins at 37°C. Sections were counterstained with Hematoxylin II. Image inset shows absence of staining in secondary antibody only control.
Customers are encouraged to optimise antigen retrieval conditions, antibody concentration, incubation times and temperature for best results in their own IHC assay workflow (automated and manual).
- WB
Unknown
Western blot - Anti-LDL Receptor antibody [EP1553Y] (AB52818)
LDL Receptor contains a number of potential glycosylation sites (SwissProt) which may explain its migration at a higher molecular weight than predicted.
All lanes:
Western blot - Anti-LDL Receptor antibody [EP1553Y] (ab52818) at 1/500 dilution
All lanes:
Human plasma total protein lysate at 10 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) preadsorbed (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-preadsorbed-ab97080'>ab97080</a>) at 1/5000 dilution
Predicted band size: 95 kDa
Observed band size: 100 kDa,27 kDa,48 kDa
true
Exposure time: 4min
- WB
Unknown
Western blot - Anti-LDL Receptor antibody [EP1553Y] (AB52818)
Blocking/Diluting buffer 5% NFDM/TBST
All lanes:
Western blot - Anti-LDL Receptor antibody [EP1553Y] (ab52818) at 1/5000 dilution
All lanes:
Mouse liver at 15 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>)
Predicted band size: 95 kDa
Observed band size: 140 kDa
false
- WB
Lab
Western blot - Anti-LDL Receptor antibody [EP1553Y] (AB52818)
Blocking buffer : 5% NFDM/TBST
Diltuion buffer : 5% NFDM/TBST
All lanes:
Western blot - Anti-LDL Receptor antibody [EP1553Y] (ab52818) at 1/1000 dilution
Lane 1:
HeLa (Human epithelial cell line from cervix adenocarcinoma) cell lysate at 20 µg
Lane 2:
HeLa treated with GW3965 for 8 hours at the final concentration of 5uM whole cell lysates at 20 µg
Lane 3:
HeLa treated with GW3965 for 24 hours at the final concentration of 5uM whole cell lysates at 20 µg
Lane 4:
Raw264.7 (Mouse macrophage cell line transformed with Abelson murine leukemia virus) whole cell lysates at 20 µg
Lane 5:
Raw264.7 treated with GW3965 for 8 hours at the final concentration of 5uM whole cell lysates at 20 µg
Lane 6:
Raw264.7 treated with GW3965 for 24 hours at the final concentration of 5uM whole cell lysates at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 95 kDa
Observed band size: 140 kDa
false
Exposure time: 1min
- WB
Lab
Western blot - Anti-LDL Receptor antibody [EP1553Y] (AB52818)
Blocking buffer : 5% NFDM/TBST
Diluting buffer : 5% NFDM/TBST
All lanes:
Western blot - Anti-LDL Receptor antibody [EP1553Y] (ab52818) at 1/1000 dilution
Lane 1:
PC-3 (Human prostate adenocarcinoma epithelial cell) whole cell lysate at 20 µg
Lane 2:
LNCaP (Human prostate carcinoma epithelial cell) whole cell lysate at 20 µg
Lane 3:
Huh7 (Human hepatocellular carcinoma epithelial cell) whole cell lysate at 20 µg
Lane 4:
HepG2 (Human hepatocellular carcinoma epithelial cell) whole cell lysate at 20 µg
Lane 5:
HeLa (Human cervix adenocarcinoma epithelial cell) whole cell lysate at 20 µg
Lane 6:
A431 (Human epidermoid carcinoma epithelial cell) whole cell lysate at 20 µg
Lane 7:
HEK-293 (Human embryonic kidney epithelial cell) whole cell lysate at 20 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated at 1/20000 dilution
Predicted band size: 95 kDa
Observed band size: 150 kDa
false
- WB
Lab
Western blot - Anti-LDL Receptor antibody [EP1553Y] (AB52818)
Blocking and diluting buffer : 5% NFDM/TBST.
The molecular weight observed is consistent with the literature (PMID : 15199428, PMID : 8349823, PMID : 10906332, PMID : 24918045).
All lanes:
Western blot - Anti-LDL Receptor antibody [EP1553Y] (ab52818) at 0.4 µg/mL
All lanes:
HepG2 (Human hepatocellular carcinoma epithelial cell) whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 95 kDa
false
Exposure time: 3min
- WB
Lab
Western blot - Anti-LDL Receptor antibody [EP1553Y] (AB52818)
Blocking buffer : 5% NFDM/TBST
Diltuion buffer : 5% NFDM/TBST
All lanes:
Western blot - Anti-LDL Receptor antibody [EP1553Y] (ab52818) at 1/1000 dilution
Lane 1:
Mouse liver lysate at 20 µg
Lane 2:
Mouse lung lysate at 20 µg
Lane 3:
Mouse colon lysate at 20 µg
Lane 4:
Human liver lysate at 20 µg
Lane 5:
HepG2 (Human liver hepatocellular carcinoma cell line) cell lysate at 20 µg
Lane 6:
HeLa (Human epithelial cell line from cervix adenocarcinoma) cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/1000 dilution
Predicted band size: 95 kDa
Observed band size: 140 kDa
false
Exposure time: 3min
Related conjugates and formulations (2)
-
HRP Anti-LDL Receptor antibody [EP1553Y]
-
Anti-LDL Receptor antibody [EP1553Y] - BSA and Azide free
Reactivity data
Product details
Product Specifications
Anti-LDL Receptor antibody [EP1553Y] (ab52818) was developed by Abcam using patented rabbit monoclonal antibody technology and is validated for use in IHC-P, WB in human, mouse samples.
Anti-LDL Receptor antibody [EP1553Y] (ab52818) specifically detects LDL Receptor (UniProt ID: P01130; Molecular weight: 93kDa) and is sold in 100 µL and 1 mL selling sizes.
Quality and Validation
Abcam's high quality manufacturing and validation processes ensure Anti-LDL Receptor antibody [EP1553Y] (ab52818) has high sensitivity and specificity alongside high lot-to-lot consistency and reproducibility.
Anti-LDL Receptor antibody [EP1553Y] (ab52818) has been cited over 145 times in peer reviewed journals and is trusted by the scientific community.
Anti-LDL Receptor antibody [EP1553Y] (ab52818) has 15 independent reviews from customers.
Related Products
Conjugation-ready, carrier free format available for antibody clone EP1553Y - ab271846.
Antibody clone EP1553Y is also available pre-conjugated to a variety of labels for your convenience - HRP (ab195516).
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
The LDL receptor interacts with LDL particles to regulate cholesterol levels in the body. It is part of a cell surface complex that recognizes and binds to apolipoprotein B-100 or apolipoprotein E present on LDL. This interaction initiates internalization of LDL leading to its degradation in lysosomes where cholesterol can be released and used by the cell. Mutations in the gene encoding LDLR can lead to inefficient cholesterol uptake influencing various metabolic processes.
Pathways
LDL receptor activities are integral to lipid metabolism and cholesterol homeostasis. Two important biological pathways that involve LDLR include the cholesterol biosynthesis pathway and the lipoprotein clearance pathway. Within these pathways LDLR collaborates closely with proteins like PCSK9 which modulates its expression and degradation and HMG-CoA reductase an important enzyme in cholesterol synthesis to balance cholesterol levels in the body.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (185)
Recent publications for all applications. Explore the full list and refine your search
Cellular and molecular life sciences : CMLS 82:313 PubMed40802025
2025
Applications
Unspecified application
Species
Unspecified reactive species
STAR protocols 6:103977 PubMed40705595
2025
Applications
Unspecified application
Species
Unspecified reactive species
Cardiovascular research 121:1373-1384 PubMed40653676
2025
Applications
Unspecified application
Species
Unspecified reactive species
JACC. Advances 4:101839 PubMed40579057
2025
Applications
Unspecified application
Species
Unspecified reactive species
Scientific reports 15:18761 PubMed40437103
2025
Applications
Unspecified application
Species
Unspecified reactive species
Scientific reports 15:15319 PubMed40312444
2025
Applications
Unspecified application
Species
Unspecified reactive species
Nature 642:776-784 PubMed40269157
2025
Applications
Unspecified application
Species
Unspecified reactive species
International journal of molecular medicine 55: PubMed40116083
2025
Applications
Unspecified application
Species
Unspecified reactive species
Scientific reports 15:6941 PubMed40011664
2025
Applications
Unspecified application
Species
Unspecified reactive species
Molecular therapy. Methods & clinical development 33:101390 PubMed39897642
2025
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com